Pinnacle Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,940	Closed	-$377K	–	170
2019 Q3	$377K	Sell	4,940 -13,563	-73%	-$1.13M	0.03%	126
2019 Q2	$1.62M	Buy	18,503 +2,120	+13%	+$181K	0.11%	64
2019 Q1	$1.48M	Buy	16,383 +670	+4%	+$57K	0.1%	64
2018 Q4	$1.13M	Sell	15,713 -10,800	-41%	-$870K	0.08%	72
2018 Q3	$2.54M	Sell	26,513 -11,271	-30%	-$1.09M	0.18%	41
2018 Q2	$3.6M	Buy	37,784 +25,336	+204%	+$2.33M	0.22%	35
2018 Q1	$1.09M	Buy	12,448 +4,643	+59%	+$424K	0.06%	77
2017 Q4	$662K	Buy	7,805 +415	+6%	+$34.8K	0.04%	113
2017 Q3	$640K	Buy	7,390 +620	+9%	+$49.7K	0.04%	105
2017 Q2	$523K	Buy	6,770 +815	+14%	+$57.8K	0.03%	112
2017 Q1	$413K	Buy	5,955 +1,870	+46%	+$126K	0.03%	128
2016 Q4	$242K	Buy	+4,085	New	+$252K	0.02%	168